Catalyst Wire Dossier Catalyst Wire Dossier

BI671800 HEA

BI671800 HEA · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI671800 HEA, covering 2013-11-01 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers [Phase 1]

See pricing